Used Cooking Oil / Uco / Acid Oil (005)
| FOB Price: | US$750.00 / Ton |
|---|---|
| Min. Order: | 10 Tons |
| Min. Order | FOB Price |
|---|---|
| 10 Tons | US$750.00/ Ton |
| Payment Terms: | L/C, D/P |
|---|
Product Description
Company Info
Address:
Heping Street Wenming Road No. 2, Shijiazhuang, Hebei, China
Business Type:
Manufacturer/Factory
Business Range:
Agriculture & Food, Chemicals, Health & Medicine, Light Industry & Daily Use, Lights & Lighting, Sporting Goods & Recreation
Management System Certification:
ISO 9001
Company Introduction:
Company profile
Hebei gensure Biological Science Co., Ltd. (gensure), founded in Shijiazhuang in 2016, is a high-tech enterprise integrating the R & D, production and sales of external testing reagents and testing equipment. Participants in national key R & D projects of the Ministry of science and technology of China, participants in key R & D projects of Hebei Province, and participants in emergency scientific research projects of Shijiazhuang science and Technology Bureau
SGS, t ü V Rheinland ISO 13485 double certification, Product CE + license from more than a dozen national health departments, and a number of invention patents.
Our plan
At present, the company has established a 2000 square meter R & D center in Shanghai Zhoupu International Medical Park, and will build a 5000 square meter R & D center in Shanghai Lingang Pujiang science and technology park by the end of 2021. The construction of Shanghai R & D center is planned to invest 200 million yuan.
The company plans to apply for 300 mu of industrial land in Shijiazhuang, invest 1.5 billion yuan, integrate upstream and downstream resources of IVD industry, introduce the most advanced technology in the industry, and build a IVD industry industrial park with the largest scale and the strongest technology in China in Shijiazhuang. The first phase will invest 500 million yuan to build the "relocation and upgrading project of Hebei jingshuo Biotechnology Co., Ltd. " and build a modern chemical plant with reference to the high-end standards of FDA and EU.
Set up R & D centers in Shanghai, Shijiazhuang and other places to build the whole industrial chain layout from biological raw materials such as antigens and antibodies to in vitro diagnostic reagents and in vitro diagnostic instruments based on existing products and technologies, so as to form a business pattern with POCT real-time diagnostic reagents as the leading products and focus on the development of molecular diagnosis, biological raw materials, diagnostic instruments and chemiluminescence microfluidic products
Based on the Beijing business center, we will lay out a nationwide and global sales platform, strengthen international registration and continue to develop overseas markets.
Our products
Virus-19 in vitro rapid detection kit
Virus-19 IgG/IgM antibody rapid detection kit (latex method) - P2002
Virus-19 antigen rapid detection kit - nasal swab -P2004
Virus-19 antigen rapid detection kit - slobber -P2004s
Virus-19 neutralization antibody rapid detection kit (fluorescence immunochromatography) -P2005
Virus-19 neutralization antibody rapid detection kit (latex method) -P2006
Virus-19 / influenza AB antigen combined detection kit (latex method) -P2007
Virus-19 and IgG antibody detection kit (latex method) -P2010
Dry fluorescent immunoanalyzer:
Immediate detection
2-15 minutes from sampling to detection completion
Accurate detection
ID card quality control, system calibration, traceability quality control, sensitivity as low as PG
User friendly design
Large touch screen, built-in printer, card insertion, automatic code scanning, identification and detection items, plug and play,
It can store 100000 test data
Flexible application sites
Bluetooth, WiFi and GPRS communication modes, hospital laboratory department, outpatient and emergency department, ICU, each clinic
Bed department, community hospital and outdoor medical scene are applicable
POCT product line
Hebei gensure Biological Science Co., Ltd. (gensure), founded in Shijiazhuang in 2016, is a high-tech enterprise integrating the R & D, production and sales of external testing reagents and testing equipment. Participants in national key R & D projects of the Ministry of science and technology of China, participants in key R & D projects of Hebei Province, and participants in emergency scientific research projects of Shijiazhuang science and Technology Bureau
SGS, t ü V Rheinland ISO 13485 double certification, Product CE + license from more than a dozen national health departments, and a number of invention patents.
Our plan
At present, the company has established a 2000 square meter R & D center in Shanghai Zhoupu International Medical Park, and will build a 5000 square meter R & D center in Shanghai Lingang Pujiang science and technology park by the end of 2021. The construction of Shanghai R & D center is planned to invest 200 million yuan.
The company plans to apply for 300 mu of industrial land in Shijiazhuang, invest 1.5 billion yuan, integrate upstream and downstream resources of IVD industry, introduce the most advanced technology in the industry, and build a IVD industry industrial park with the largest scale and the strongest technology in China in Shijiazhuang. The first phase will invest 500 million yuan to build the "relocation and upgrading project of Hebei jingshuo Biotechnology Co., Ltd. " and build a modern chemical plant with reference to the high-end standards of FDA and EU.
Set up R & D centers in Shanghai, Shijiazhuang and other places to build the whole industrial chain layout from biological raw materials such as antigens and antibodies to in vitro diagnostic reagents and in vitro diagnostic instruments based on existing products and technologies, so as to form a business pattern with POCT real-time diagnostic reagents as the leading products and focus on the development of molecular diagnosis, biological raw materials, diagnostic instruments and chemiluminescence microfluidic products
Based on the Beijing business center, we will lay out a nationwide and global sales platform, strengthen international registration and continue to develop overseas markets.
Our products
Virus-19 in vitro rapid detection kit
Virus-19 IgG/IgM antibody rapid detection kit (latex method) - P2002
Virus-19 antigen rapid detection kit - nasal swab -P2004
Virus-19 antigen rapid detection kit - slobber -P2004s
Virus-19 neutralization antibody rapid detection kit (fluorescence immunochromatography) -P2005
Virus-19 neutralization antibody rapid detection kit (latex method) -P2006
Virus-19 / influenza AB antigen combined detection kit (latex method) -P2007
Virus-19 and IgG antibody detection kit (latex method) -P2010
Dry fluorescent immunoanalyzer:
Immediate detection
2-15 minutes from sampling to detection completion
Accurate detection
ID card quality control, system calibration, traceability quality control, sensitivity as low as PG
User friendly design
Large touch screen, built-in printer, card insertion, automatic code scanning, identification and detection items, plug and play,
It can store 100000 test data
Flexible application sites
Bluetooth, WiFi and GPRS communication modes, hospital laboratory department, outpatient and emergency department, ICU, each clinic
Bed department, community hospital and outdoor medical scene are applicable
POCT product line
